According to information disclosed by CRO Analytics, $30,000 was subscribed by one investor on February 6th 2014. CRO Analytics capped the non-brokered equity backed financing at $500,000. An additional $480,000 in funding can be raised until the offering draws to a close in February 2015. The company is filing for the first time a security registration exemption with the SEC.
The company is developing a database to collect, analyze, and report data on performance of clinical research organizations (CRO) and other related research service providers. CRO Analystics doesn’t seem to have launched its product as of yet.
The company, headquartered in New Hope PA, is led by Peter B. Malamis (Chief Executive Officer). CRO Analytics elected to keep its revenues undisclosed.
Status: First close
Company: CRO Analytics
Industry: Other Technology
Amount offered: $500,000
Amount placed: $30,000
First sale: 2014-02-06